Medindia
Medindia LOGIN REGISTER
Advertisement

Cynosure to Announce Fourth-quarter and Full-year 2008 Financial Results on February 10

Wednesday, January 21, 2009 General News
Advertisement
WESTFORD, Mass., Jan. 20 Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that the company will host its fourth-quarter and full-year 2008 conference call on Tuesday, February 10, 2009 at 9:00 a.m. ET.
Advertisement



On the call, President and Chief Executive Officer Michael Davin and Executive Vice President and Chief Financial Officer Timothy Baker will discuss Cynosure's financial results, as well as the company's business outlook and strategy.
Advertisement



Those who wish to listen to the conference call webcast should visit the "Investor Relations" section of the company's website at www.cynosure.com. The live call also can be accessed by dialing (877) 407-5790 or (201) 689-8328. If you are unable to listen to the live call, the webcast will be archived on the company's website.



About Cynosure, Inc.



Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, liquefy and remove unwanted fat through laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991.



For corporate or product information, contact Cynosure at 800-886-2966, or visit www.cynosure.com.



Contact Scott Solomon Vice President Sharon Merrill Associates, Inc. 617-542-5300 [email protected]

SOURCE Cynosure, Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close